Mianus Capital

Mianus Capital is not just another biotech VC! We leverage our collaborating CRO ) company’s unparalleled expertise and resource in clinical research to do venture investing. Our CRO provides technology and service for clinical trials across ophthalmology, oncology and respiratory. It is an "insider" in the drug development ecosystem and a global category leader in ophthalmology. We are building a differentiated VC company consisting of a portfolio of specialist VC funds each targeting a therapeutic vertical like ophthalmology and oncology. We believe this CRO+VC “specialist” approach is incredibly unique and compelling. Our mission at Mianus Capital is to make early-stage investment to drive innovation in life sciences and healthcare. We also want to make a profound social impact by supporting initiatives that address unmet medical needs, affordability, and inclusivity in global healthcare. We expect to deliver exceptional returns for our investor, because we work closely and invest alongside with our advisors/venture partners who are the most active and accomplished investors and innovators in each therapeutic area ( ophthalmology example: https://meritcro.com/ophthalmology-scientific-advisory-council/). This closes tie with insiders of ecosystem is really the “secret sauce” of our business model.